Vaccination as a new form of cardiovascular prevention: an ESC Clinical Consensus Statement
Peer-Reviewed Publication
Updates every hour. Last Updated: 9-Oct-2025 00:11 ET (9-Oct-2025 04:11 GMT/UTC)
A newly published ESC Clinical Consensus Statement describes the pivotal role of vaccination in the prevention of cardiovascular events.
Infections such as pneumonia, influenza and SARS-CoV-2, among others, exacerbate heart failure and increase the risk of major cardiovascular events. In addition to preventing infections, vaccination can reduce cardiovascular complications, particularly in at-risk patients with existing cardiovascular disease.
The new document concludes that vaccination should be considered as a foundational pillar for cardiovascular prevention alongside other established measures.
A new national survey of 1,000 American adults commissioned by The Ohio State University Wexner Medical Center and College of Medicine finds that stress and anxiety contribute most to a short attention span (43%), followed by lack of sleep (39%) and digital devices (35%).
As public health insurance in the United States faces potential cuts, a Rutgers University review of medical records finds that Medicaid and Medicare patients with opioid addiction tend to receive behavioral health care services less often than those with other types of funding.
A new Australian study is shining a spotlight on the healing power of horses, revealing that equine-assisted therapy could help address the growing mental health crisis among children.
Using a cell-free RNA (cfRNA) “liquid biopsy” of maternal plasma, researchers at the Carlos Simon Foundation and iPremom enrolled 9,586 pregnant women from 14 hospitals across Spain between September 2021 and June 2024. In a nested case-control analysis of 216 participants, they successfully predicted both early-onset and late-onset preeclampsia well before the onset of symptoms.
Scientists from Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, have developed a novel ultrasound-driven therapy that activates dormant cancer drugs directly inside tumors. By combining low-intensity ultrasound with specially designed nanoparticles, the team achieved a 99% tumor suppression rate and 66.7% cure rate in mice. This non-invasive approach minimizes side effects and could revolutionize targeted cancer treatment.
The β cell proliferation capacity determines its mass and islet function, thus playing a pivotal role in maintaining glucose homeostasis. A study published in Science Bulletin Journal reported a pancreatic endogenous ribonuclease 4 (Rnase4), which governs β cell number and islet size under both physiological and pathological conditions. This factor is selectively expressed in β cells and acts in a cell-autonomous manner to drive β cell proliferation through the Axl-PI3K/Akt/FoxO1/Pdx1 signaling pathway. Absence of Rnase4 diminished β cell population, leading to systemic insulin deficiency; exogenous supplementation of this factor could rescue β cell loss and islet dysfunction induced by genetic, chemical, or inflammatory challenges. The findings highlight a key β-cell self-derived factor in regulating its proliferation and body glucose metabolism.